Arch Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q1 2012 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Arch Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q1 2012 to Q3 2024.
  • Arch Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending August 19, 2024 was 4.44M shares.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 4.44M Aug 19, 2024 10-Q 2024-08-19
Q1 2024 4.44M May 1, 2024 10-Q 2024-05-09
Q4 2023 4.74M -245M -98.1% Feb 14, 2024 10-K/A 2024-03-01
Q2 2023 3.09M -247M -98.8% Aug 11, 2023 10-Q 2023-08-11
Q4 2022 250M +12.8M +5.38% Dec 28, 2022 10-K 2022-12-28
Q2 2022 250M +13.2M +5.58% Aug 11, 2022 10-Q 2022-08-11
Q1 2022 237M +350K +0.15% May 13, 2022 10-Q 2022-05-13
Q4 2021 237M +44.1M +22.9% Dec 16, 2021 10-K/A 2021-12-29
Q2 2021 237M +43.7M +22.6% Aug 12, 2021 10-Q 2021-08-13
Q1 2021 237M +48.9M +26% May 5, 2021 10-Q 2021-05-06
Q4 2020 193M +5.18M +2.76% Dec 10, 2020 10-K 2020-12-11
Q2 2020 193M +19.5M +11.2% Jul 22, 2020 10-Q 2020-07-23
Q1 2020 188M +14.3M +8.23% May 4, 2020 10-Q 2020-05-05
Q4 2019 188M +23.4M +14.2% Jan 29, 2020 10-Q 2020-01-30
Q2 2019 174M +9.28M +5.65% Jul 31, 2019 10-Q 2019-08-01
Q1 2019 174M +19.5M +12.7% May 14, 2019 10-Q 2019-05-14
Q4 2018 164M +10.4M +6.74% Dec 17, 2018 10-K 2018-12-18
Q2 2018 164M +13.5M +8.97% Aug 1, 2018 10-Q 2018-08-02
Q1 2018 154M +3.28M +2.18% Apr 25, 2018 10-Q 2018-04-26
Q4 2017 154M +16.2M +11.7% Jan 31, 2018 10-Q 2018-02-01
Q3 2017 154M Nov 14, 2017 10-K 2017-11-15
Q2 2017 151M +16.6M +12.3% Jul 26, 2017 10-Q 2017-07-27
Q1 2017 151M +33.9M +29.1% May 1, 2017 10-Q 2017-05-02
Q4 2016 138M +29M +26.6% Dec 2, 2016 10-K 2016-12-05
Q2 2016 134M +33.6M +33.4% Jul 27, 2016 10-Q 2016-07-28
Q1 2016 117M +40.8M +53.6% Apr 27, 2016 10-Q 2016-04-28
Q4 2015 109M +32.8M +43.1% Dec 10, 2015 10-K 2015-12-11
Q2 2015 101M +28.6M +39.6% Aug 5, 2015 10-Q 2015-08-07
Q1 2015 76.1M +4M +5.55% May 7, 2015 10-Q 2015-05-07
Q4 2014 76.1M +15.9M +26.5% Dec 10, 2014 10-K 2014-12-12
Q2 2014 72.1M +12.9M +21.9% Aug 5, 2014 10-Q 2014-08-06
Q1 2014 72.1M +68.1M +1720% May 1, 2014 10-K/A 2014-05-01
Q4 2013 60.1M +54.1M +897% Dec 26, 2013 10-K 2013-12-27
Q2 2013 59.1M +53.1M +881% Aug 13, 2013 10-Q 2013-08-14
Q1 2013 3.96M -40K -1% May 15, 2013 10-Q 2013-05-20
Q4 2012 6.03M Dec 31, 2012 10-Q 2013-02-14
Q3 2012 6.03M Sep 30, 2012 10-K 2012-12-31
Q2 2012 6.03M Jun 30, 2012 10-Q 2012-08-14
Q1 2012 4M Mar 31, 2012 10-Q 2012-05-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.